A multiple drug fatality involving MK-801 (dizocilpine), a mimic of phencyclidine

Forensic Science International

Volumn 133, Issue 1-2, 2003, Pages 113-117

  Mozayani, Ashraf ^a   Schrode, Paul ^a   Carter, Joye ^a   Danielson, Terry J ^a  

^a Harris County Medical Examiner's Office   (United States)

Author keywords

Dizocilpine; Human; MK 801; Phencyclidine; Post mortem; Toxicology

Indexed keywords

ALCOHOL; BENZODIAZEPINE; DIZOCILPINE; ORGANIC SOLVENT; PHENCYCLIDINE; PROADIFEN;

ADULT; ALCOHOL INTOXICATION; AUTOPSY; BILE; BLOOD ANALYSIS; BODY WEIGHT; BRAIN DISEASE; BUILDING; CADAVER; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; CONFERENCE PAPER; DEPRESSION; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG INTOXICATION; FORENSIC PATHOLOGY; GAS CHROMATOGRAPHY; HEALTH STATUS; HEART; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; KIDNEY; LIVER; LUNG CONGESTION; LUNG EDEMA; MALE; MASS SPECTROMETRY; MICROSCOPY; PRIORITY JOURNAL; SELF EVALUATION; SOLVENT EXTRACTION; STOMACH CONTENT; UNITED STATES; URINALYSIS; VITREOUS BODY;

EID: 0038706367     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(03)00070-7     Document Type: Conference Paper

References (16)

1. Wong E.H., Kemp J.A., Priestly T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7104-7108.
2. Sircar R., Rappaport M., Nichtenhauser R., Zukin S.R. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor. Brain Res. 435:1987;235-240.
3. Biochemical Diagnostics Inc., Detectabuse Gravity Series GV-65 Method for the Analyses of Benzodiazepines in Whole Blood or Serum by GC/MS, Edgewood, NY, 1997.
4. Newcomer J.W., Farber N., Jevtovic-Todrovic V., Selke G., Kelly A., Williams F., Craft S., Olney J.W. NMDA glutamate receptor hypofunction: a model for schizophrenia-like cognitive and behavioral symptoms. Soc. Neurosci. Abst. 22:1996;1274.
5. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurones by phencyclidine and related drugs. Science. 244:1989;1360-1362.
6. Brosnan-Watters G., Wozniak D.F., Nardi A., Olney J.W. Parallel recovery of MK-801 induced spatial learning impairment and neuronal injury in male mice. Pharmacol. Biochem. Behav. 62:1999;111-122.
7. Pitkanen M., Sirvio J., MacDonald E., Niemi S., Eksonsalo T., Riekkinen P. The effects of D-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks. Eur. J. Neuropsychopharmacol. 5:1995;457-463.
8. Mathe J.M., Nomikos G.G., Hildebrand B.E., Hertel P., Svensson T.H. Prazosin inhibits MK-801 hyperlocomotion and dopamine release in the nucleus accumbens. Eur. J. Pharmacol. 301:1996;1-11.
9. Rosen G.D., Sigel E.A., Sherman G.F., Galaburda A.M. The neuroprotective effects of MK-801 on the induction of myrogyria by freezing injury to the newborn rat neocortex. Neuroscience. 69:1995;107-114.
10. Popke E.J., Patton R., Newport G.D., Rushing L.G., Fogle C.M., Allen R.R., Pearson E.C., Hammond T.G., Paule M.G. Assessing the potential toxicity of MK-801 and remacemide: chronic exposure in juvenile rhesus monkeys. Neurotoxicol. Teratol. 24:2002;193-207.
11. Kunsman G.W., Levine B., Costantino A., Smith M.L. Phencyclidine blood concentrations in DRE cases. J. Anal. Toxicol. 21:1997;498-502.
12. Cravey R.H., Reed D., Ragle J.L. Phencyclidine related deaths: a report of nine fatal cases. J. Anal. Toxicol. 3:1979;199-201.
13. Linnoila M., Matilla M.J., Kitchell B.S. Drug interactions with alcohol. Drugs. 18:1979;299-311.
14. Koek W., Colpaert F.C., Woods J.H., Kamenka J.M. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl)cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. J. Pharmacol. Exp. Ther. 250:1989;1019-1027.
15. de Costa B.R., Bowden W.D., Hellewell S.B., George C., Rothman R.B., Reid A.A., Walker J.M., Jacobson A.E., Rice K.C. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high affinity sigma ligands. J. Med. Chem. 32:1989;1996-2002.
16. Arai A., Kessler M., Xiao P., Ambros-Ingerson J., Rogers G., Lynch G. A centrally active drug that modulates AMPA receptor gated currents. Brain Res. 638:1994;343-346.